Kevin Schultz Net Worth & Insider Trades
Kevin Schultz - Chief Scientific Officer, Kindred Biosciences, Inc
What is Kevin Schultz's Net Worth?
The current estimated net worth of Kindred Biosciences, Inc's Chief Scientific Officer, Kevin Schultz, is estimated to be about $28K . Kevin Schultz owns about 4,000 units of Kindred Biosciences, Inc common stock. In the last year at Kindred Biosciences, Inc, Kevin Schultz has sold an estimated value of $0 worth.
What is Kevin Schultz's Past Insider Trading?
Kevin Schultz's largest purchase order was 4,000 units , worth over $28K on December 13, 2013. In total, Kevin Schultz has made about 2 transactions over a year of their time at Kindred Biosciences, Inc. Kevin Schultz usually trades in December and February, with the busiest year in 2014 and 2013.
Kevin Schultz
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Kevin Schultz's' Mailing Address?
- Mailing address is C/o Kindred Biosciences, Inc. 1499 Bayshore Highway, Suite 226 Burlingame CA 94010 CA
Kindred Biosciences, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Richard Chin, M.D. | 2020 | $650,000 | $170,625 | $1,476,000 | $1,570,968 | - | $3,867,593 |
| Richard Chin, M.D. | 2019 | $620,000 | $279,000 | $495,500 | $2,198,888 | - | $3,593,388 |
| Richard Chin, M.D. | 2018 | $520,000 | $223,600 | $1,312,500 | $877,870 | - | $2,933,970 |
| Denise Bevers | 2020 | $278,250 | - | $393,600 | $418,925 | $1,162,688 | $2,253,463 |
| Denise Bevers | 2019 | $455,000 | $178,133 | - | $824,583 | - | $1,457,716 |
| Denise Bevers | 2018 | $414,271 | $176,289 | $962,500 | $1,034,621 | - | $2,587,681 |
| Wendy Wee | 2020 | $362,000 | $43,440 | $246,000 | $261,828 | - | $913,268 |
| Wendy Wee | 2019 | $345,000 | $93,150 | - | $549,722 | - | $987,872 |
| Wendy Wee | 2018 | $330,000 | $84,500 | $262,500 | $376,230 | - | $1,053,230 |
| Hangjun Zhan, Ph.D. | 2020 | $362,000 | $48,870 | $246,000 | $261,828 | - | $918,698 |
| Hangjun Zhan, Ph.D. | 2019 | $345,000 | $87,975 | - | $549,722 | - | $982,697 |
| Hangjun Zhan, Ph.D. | 2018 | $330,000 | $89,100 | $218,750 | $401,312 | - | $1,039,162 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1561743/000156174321000030/a2021definitiveproxystatem.htm
What are Kindred Biosciences, Inc's Past Insider Trades?
Kindred Biosciences, Inc's most recent insider trade came on August 30, 2021 by Elanco Animal Health Inc who bought 45,508,938 units worth $420.96M . In the last 8 years, insiders at Kindred Biosciences, Inc have sold an estimated value of $31.64M and bought an estimated value of $462.19M worth of shares. Insider trading is most common in January, with the busiest year in 2021. The most active traders at the company are Richard Chin, Chief Executive Officer, Park West Asset Management Llc, and Denise Bevers, Director .
Kindred Biosciences, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||